Skip to main content
Veterinary Medicines

Parafend Plus Oral Suspension

Authorised
  • Oxfendazole
  • Closantel

Product identification

Medicine name:
Parafend Plus Oral Suspension
DUOTECH
Active substance:
  • Oxfendazole
  • Closantel
Target species:
  • Sheep
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Oxfendazole
    25.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Closantel
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Sheep
      • Meat and offal
        42
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC52
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • White low-density polyethylene backpacks of 1L.
  • White low-density polyethylene backpacks of 2.5 L.
  • White low-density polyethylene backpacks of 5 L.
  • White low-density polyethylene backpacks of 2 x 5 L.
  • White low-density polyethylene 10L jerry-can.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Norbrook Laboratories Limited
  • Norbrook Manufacturing Limited
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/8345859 2/2004
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0149/001
Concerned member states:
  • France
  • Italy
  • Portugal
  • Spain

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
French (PDF)
Published on: 4/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."